These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Apoptosis in malignant glioma cells triggered by the temozolomide-induced DNA lesion O6-methylguanine. Roos WP; Batista LF; Naumann SC; Wick W; Weller M; Menck CF; Kaina B Oncogene; 2007 Jan; 26(2):186-97. PubMed ID: 16819506 [TBL] [Abstract][Full Text] [Related]
6. Sensitization of pancreatic tumor xenografts to carmustine and temozolomide by inactivation of their O6-Methylguanine-DNA methyltransferase with O6-benzylguanine or O6-benzyl-2'-deoxyguanosine. Kokkinakis DM; Ahmed MM; Chendil D; Moschel RC; Pegg AE Clin Cancer Res; 2003 Sep; 9(10 Pt 1):3801-7. PubMed ID: 14506174 [TBL] [Abstract][Full Text] [Related]
8. O6-methylguanine DNA methyltransferase and p53 status predict temozolomide sensitivity in human malignant glioma cells. Hermisson M; Klumpp A; Wick W; Wischhusen J; Nagel G; Roos W; Kaina B; Weller M J Neurochem; 2006 Feb; 96(3):766-76. PubMed ID: 16405512 [TBL] [Abstract][Full Text] [Related]
9. Mitochondrial targeting of human O6-methylguanine DNA methyltransferase protects against cell killing by chemotherapeutic alkylating agents. Cai S; Xu Y; Cooper RJ; Ferkowicz MJ; Hartwell JR; Pollok KE; Kelley MR Cancer Res; 2005 Apr; 65(8):3319-27. PubMed ID: 15833865 [TBL] [Abstract][Full Text] [Related]
10. Adenovirus-based strategies overcome temozolomide resistance by silencing the O6-methylguanine-DNA methyltransferase promoter. Alonso MM; Gomez-Manzano C; Bekele BN; Yung WK; Fueyo J Cancer Res; 2007 Dec; 67(24):11499-504. PubMed ID: 18089777 [TBL] [Abstract][Full Text] [Related]
11. The L84F polymorphic variant of human O6-methylguanine-DNA methyltransferase alters stability in U87MG glioma cells but not temozolomide sensitivity. Remington M; Chtchetinin J; Ancheta K; Nghiemphu PL; Cloughesy T; Lai A Neuro Oncol; 2009 Feb; 11(1):22-32. PubMed ID: 18812520 [TBL] [Abstract][Full Text] [Related]
13. IFN-beta down-regulates the expression of DNA repair gene MGMT and sensitizes resistant glioma cells to temozolomide. Natsume A; Ishii D; Wakabayashi T; Tsuno T; Hatano H; Mizuno M; Yoshida J Cancer Res; 2005 Sep; 65(17):7573-9. PubMed ID: 16140920 [TBL] [Abstract][Full Text] [Related]
14. Hypoxia enhances the replication of oncolytic herpes simplex virus. Aghi MK; Liu TC; Rabkin S; Martuza RL Mol Ther; 2009 Jan; 17(1):51-6. PubMed ID: 18957963 [TBL] [Abstract][Full Text] [Related]
15. Interleukin-24 overcomes temozolomide resistance and enhances cell death by down-regulation of O6-methylguanine-DNA methyltransferase in human melanoma cells. Zheng M; Bocangel D; Ramesh R; Ekmekcioglu S; Poindexter N; Grimm EA; Chada S Mol Cancer Ther; 2008 Dec; 7(12):3842-51. PubMed ID: 19056673 [TBL] [Abstract][Full Text] [Related]
17. Anti-glioma therapy with temozolomide and status of the DNA-repair gene MGMT. Fukushima T; Takeshima H; Kataoka H Anticancer Res; 2009 Nov; 29(11):4845-54. PubMed ID: 20032445 [TBL] [Abstract][Full Text] [Related]
18. Role of O6-methylguanine-DNA methyltransferase in resistance of human brain tumor cell lines to the clinically relevant methylating agents temozolomide and streptozotocin. Bobola MS; Tseng SH; Blank A; Berger MS; Silber JR Clin Cancer Res; 1996 Apr; 2(4):735-41. PubMed ID: 9816224 [TBL] [Abstract][Full Text] [Related]
19. O(6)-methylguanine DNA-methyltransferase (MGMT) overexpression in melanoma cells induces resistance to nitrosoureas and temozolomide but sensitizes to mitomycin C. Passagne I; Evrard A; Depeille P; Cuq P; Cupissol D; Vian L Toxicol Appl Pharmacol; 2006 Mar; 211(2):97-105. PubMed ID: 16039682 [TBL] [Abstract][Full Text] [Related]
20. Inhibition of DNA repair for sensitizing resistant glioma cells to temozolomide. Kanzawa T; Bedwell J; Kondo Y; Kondo S; Germano IM J Neurosurg; 2003 Dec; 99(6):1047-52. PubMed ID: 14705733 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]